Literature DB >> 25444256

Use of emollients in atopic dermatitis.

J P X Ng1, H M Liew, S B Ang.   

Abstract

Atopic dermatitis (AD) is a common inflammatory skin disorder that has strong financial and psychosocial impacts. Its pathogenesis is related to increased transepidermal water loss due to a defective skin epidermal barrier. Emollients serve as first-line therapy during both acute flares and remission. However, their use is poorly characterized, posing therapeutic challenges to clinicians and patients. In this article, we review available evidence to provide recommendations, aiming to standardize and optimize the use of emollients in AD. Literature search was performed using Pubmed and Google. All articles were retrieved using Pubmed. Recommendations were graded based on the British Medical Journal's Grading of Recommendations Assessment, Development and Evaluation system and the American Academy of Family Physicians' Strength of Recommendation Taxonomy. Emollients should be applied post-bathing. However, the need for immediate application is debatable. The optimal frequency for application is still undetermined, but multiple applications daily are encouraged. Ideally, a balance should be achieved between patient's compliance and clinical efficacy. Emollients hold the potential to act as steroid-sparing agents, but more well-designed studies are pertinent for a definite conclusion. At present, it is recommended that 250-500 g of emollients be applied every week. Finally, primary prevention of AD by regular application of emollients in high-risk infants cannot yet be recommended.
© 2014 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25444256     DOI: 10.1111/jdv.12864

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  4 in total

1.  Efficacy and Tolerability of a Medical Device Repairing Emollient Cream Associated with a Topical Corticosteroid in Adults with Atopic Dermatitis: An Open-label, Intra-individual Randomized Controlled Study.

Authors:  Ana Beatris Rossi; Adeline Bacquey; Thérèse Nocera; Marie-Dominique Thouvenin
Journal:  Dermatol Ther (Heidelb)       Date:  2018-03-06

2.  Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study.

Authors:  Susana Garcia de Arriba; Lisa Grüntkemeier; Manuel Häuser; Theodor W May; Clarissa Masur; Petra Stute
Journal:  PLoS One       Date:  2022-05-12       Impact factor: 3.240

Review 3.  Use of Dexpanthenol for Atopic Dermatitis-Benefits and Recommendations Based on Current Evidence.

Authors:  Yoon Sun Cho; Hye One Kim; Seung Man Woo; Dong Hun Lee
Journal:  J Clin Med       Date:  2022-07-06       Impact factor: 4.964

Review 4.  Treating pediatric atopic dermatitis: current perspectives.

Authors:  Victoria R Dimitriades; Elizabeth Wisner
Journal:  Pediatric Health Med Ther       Date:  2015-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.